JOIN US
Liquid Biopsy in Advanced NSCLC: Stay Up to Date 

When a liquid biopsy report identifies a targetable driver, treatment decisions are clear. When there is no driver identified, the next steps are more uncertain. Expert speakers will present their perspectives on liquid biopsy for treatment selection in NSCLC and discuss emerging biomarker ctDNA tumor fraction reported on Foundation Medicine’s liquid biopsy test.